NFKB1 and renal cell carcinoma: VHL loss could activate NF-κB pathways [107], thereby inducing gene expression of anti-apoptotic Bcl-xL and Bcl-2, and inhibiting tumor suppressor p53, highlighting the potential role in RCC development [108].